Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways

被引:156
作者
Arbuthnot, P
Capovilla, A
Kew, M
机构
[1] Univ Witwatersrand, Sch Med, Dept Med, Mol Hepatol Res Unit, ZA-2193 Johannesburg, South Africa
[2] Univ Witwatersrand, Sch Med, Dept Mol Med & Haematol, ZA-2193 Johannesburg, South Africa
关键词
apoptosis; DNA repair; HBx; hepatitis B virus; Janus kinases/signal transducer and activators of transcription (JAK/STAT); mitogen-activated protein kinase; p53;
D O I
10.1046/j.1440-1746.2000.02069.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic infection with hepatitis B virus (HBV) is a major risk factor for the development of hepatocellular carcinoma (HCC). The pathogenesis of HBV-induced malignant transformation is, however, incompletely understood. HBx, the protein encoded by the X open reading frame, is a transcriptional activator that has been implicated in hepatocarcinogenesis. HBx inhibits the function of the tumour suppressor protein p53 in what is thought to be an early event in hepatocyte transformation before the later accumulation of inactivating p53 point mutations. HBx inhibits apoptosis but also exerts pro-apoptotic effects. The effects of HBx on apoptosis may be important not only for the development of HCC but also for the establishment of HBV infection. Further implication of HBx in hepatocyte transformation has been the demonstration that it inhibits the repair of damaged hepatocyte DNA. This effect may be mediated by interaction with p53 or through binding to the damaged DNA binding protein (DDB), which plays an accessory role in nucleotide excision repair. In addition, HBx activates cell signalling cascades involving mitogen-activated protein kinase (MAPK) and Janus family tyrosine kinases (JAK)/signal transducer and activators of transcription (STAT) pathways. The implications of these modulating effects of HBx are not fully understood, but they are likely to have wide-ranging effects on hepatocyte proliferation, apoptosis and the regulation of cell growth checkpoints. The cellular functions ascribed to HBx are unusually diverse, and defining the biologically important role of HBx during HBV replication will go some way to understanding the sequelae of chronic HBV infection. (C) 2000 Blackwell Science Asia Pty Ltd.
引用
收藏
页码:357 / 368
页数:12
相关论文
共 132 条
[81]
Signaling to p53: Breaking the MDM2-p53 circuit [J].
Prives, C .
CELL, 1998, 95 (01) :5-8
[82]
Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes [J].
Prost, S ;
Ford, JM ;
Taylor, G ;
Doig, J ;
Harrison, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (50) :33327-33332
[83]
Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH [J].
Qadri, I ;
Conaway, JW ;
Conaway, RC ;
Schaack, J ;
Siddiqui, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10578-10583
[84]
Cellular responses to interferons and other cytokines: The JAK-STAT paradigm [J].
Ransohoff, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (09) :616-618
[85]
BCL-2 AND THE REGULATION OF PROGRAMMED CELL-DEATH [J].
REED, JC .
JOURNAL OF CELL BIOLOGY, 1994, 124 (1-2) :1-6
[86]
THE C-TERMINAL DOMAIN OF P53 RECOGNIZES DNA DAMAGED BY IONIZING-RADIATION [J].
REED, M ;
WOELKER, B ;
WANG, P ;
WANG, Y ;
ANDERSON, ME ;
TEGTMEYER, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9455-9459
[87]
ROBINSON WS, 1994, ANNU REV MED, V45, P297
[88]
GENETIC DISSECTION OF A NEURODEVELOPMENTAL PATHWAY - SON OF SEVENLESS FUNCTIONS DOWNSTREAM OF THE SEVENLESS AND EGF RECEPTOR TYROSINE KINASES [J].
ROGGE, RD ;
KARLOVICH, CA ;
BANERJEE, U .
CELL, 1991, 64 (01) :39-48
[89]
Ras - a versatile cellular switch [J].
Rommel, C ;
Hafen, E .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (04) :412-418
[90]
REVIEW - HEPATITIS-B VIRUS X-GENE PRODUCT - A PROMISCUOUS TRANSCRIPTIONAL ACTIVATOR [J].
ROSSNER, MT .
JOURNAL OF MEDICAL VIROLOGY, 1992, 36 (02) :101-117